Key result
Invasive strategy reduces all-cause mortality ~25% vs. conservative management in older adults with NSTEMI.
Why the study?
Older adults with NSTEMI are often undertreated invasively due to concerns about risks and comorbidities, and their limited inclusion in clinical trials leaves a gap in evidence-based management.
Does an invasive strategy reduce the composite of all-cause mortality and non-fatal MI in older adults ≥70 years with NSTEMI compared to a conservative strategy?
Meta-Analysis (n=4,114)
Does an invasive strategy reduce the composite of all-cause mortality and non-fatal MI in older adults ≥70 years with NSTEMI compared to a conservative strategy?
An invasive strategy in NSTEMI patients aged ≥70 years significantly reduces the composite of all-cause mortality and non-fatal MI, as well as the need for revascularization, without increasing mortality.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Supports invasive strategy in older NSTEMI patients; reinforces consensus from prior randomized trials.
Background Older adults with Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) are often undertreated invasively due to concerns about risks and comorbidities, despite potential benefits. Their limited inclusion in clinical trials leaves a gap in evidence-based management. This meta-analysis compared invasive versus conservative strategies in elderly NSTEMI patients.Methods A systematic search was conducted across PubMed, CENTRAL, Web of Science, Scopus, and Embase through December 2024. Pooled results were reported using risk ratios (RR) for dichotomous outcomes and mean differences (MD) for continuous outcomes with 95% confidence intervals (CI).Results A total of 11 randomized controlled trials involving 4114 patients were included. Invasive treatment significantly reduced the composite of all-cause mortality and non-fatal MI (RR: 0.82; 95% CI: 0.68–0.99; p = 0.04) and MI alone (RR: 0.68; 95% CI: 0.56–0.84; p = 0.0003). There was no significant difference in all-cause mortality (RR: 1.04; 95% CI: 0.92–1.16; p = 0.55) or cardiovascular death (RR: 0.96; 95% CI: 0.78–1.18; P = 0.67). Invasive strategy significantly lowered the need for revascularization (RR: 0.29; 95% CI: 0.21–0.40; p < 0.0001).Conclusion In NSTEMI patients aged ≥70, invasive management reduces the risk of MI and revascularization without increasing mortality risk. More elderly-focused trials are warranted.Protocol Registration https://www.crd.york.ac.uk/prospero identifier is CRD42025633157.
Khan et al. (2026) conducted a meta-analysis in Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) (n=4,114). Invasive strategy vs. Conservative strategy was evaluated on Composite of all-cause mortality and non-fatal MI (RR 0.82, 95% CI 0.68-0.99, p=0.04). Invasive management reduced the composite of all-cause mortality and non-fatal MI compared to a conservative strategy in NSTEMI patients aged ≥70.
Synapse has enriched 10 related papers. Consider them for comparative context: